戻る Agenda
Special Session: Opening Plenary
Session Chair(s)
Tatsuo Kurokawa, DIAFellow, PHD
Director General
The Japan Biosimilar Association, Japan
Speaker(s)
Future visions for international regulatory collaboration: Australian perspective
John Skerritt, PHD
University of Melbourne, Australia
Enterprise Professor, Health Research Impact
Tatsuya Kondo, MD, PHD
SH Medical Excellence JAPAN, Japan
President